ULMS

Clinical trials for ULMS explained in plain language.

Never miss a new study

Get alerted when new ULMS trials appear

Sign up with your email to follow new studies for ULMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New drug targets Hormone-Fueled uterine sarcomas

Disease control Recruiting now

This study tests a drug called elacestrant in people with advanced uterine sarcomas that are fueled by estrogen. The drug works by blocking and breaking down estrogen receptors on cancer cells. About 30 participants will receive the drug to see if it can shrink tumors and control…

Matched conditions: ULMS

Phase: PHASE2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control

Last updated May 12, 2026 13:42 UTC

ULMS

Get alerted when new ULMS trials appear

New drug targets Hormone-Fueled uterine sarcomas